Audience Personas
The MedTech Angel Investor
A former healthcare executive or exit-founder who invests personal capital into early-stage medical devices and clinical software. They look for massive improvements in patient outcomes and proprietary IP.
Pain Points
- High risk of clinical trial failure
- Opaque regulatory pathways for dynamic waveforms
- Difficulty finding high-signal prototypes in the crowded chronic pain market
Where They Hang Out
Messaging Angle
“Pearl Dynamics solves the 'habituation' problem of SCS by using dynamic waveforms, potentially increasing long-term efficacy and reducing device abandonment rates—a key metric for acquisition.”
The Chronic Pain Patient (The Validator)
Patients currently using spinal cord stimulation (SCS) who have become 'habituated' (the therapy stopped working). They are the primary source of social proof needed to attract investors.
Pain Points
- Returning pain after initial SCS success
- Complexity of managing pulse settings
- Desire for non-opioid long-term solutions
Where They Hang Out
Messaging Angle
“Stop the fading effect of your stimulator. Dynamic waveforms adapt to your body's needs to ensure long-term relief without manual adjustments.”
Innovation Scout (Corporate VC)
Individuals working for major device manufacturers (Medtronic, Abbott, Boston Scientific) looking for early-stage M&A or strategic investment opportunities.
Pain Points
- Losing market share to newer, more adaptive technologies
- Need for data-driven evidence of better patient compliance
- Shortage of innovative dynamic waveform IP
Where They Hang Out
Messaging Angle
“Integrating dynamic waveform generation into legacy hardware to extend product lifecycle and patient satisfaction.”
Distribution Map
Weekly Plan
1Investor Infrastructure
Digital footprint established and first 2-3 investor matches identified.
Create and optimize the company profile. Upload the logo, define the MedTech/BioTech categories, and link to the prototype landing page.
Crunchbaseai assistedPost a 'Thesis' post explaining why static waveforms are failing 40% of SCS patients within 2 years. Target the post at MedTech VCs.
LinkedInone tap
Key Metrics
- Number of Investor First-Meetings scheduled
- Investor Pitch Deck click-through/view rate (via DocSend or similar)
- Number of Patient 'Validations' (Waitlist signups or survey completions)
- LinkedIn Profile Views from 'Venture Capital' or 'Medical Devices' personas
- Accelerator/Pitch Competition application status
Risks & Challenges
- FDA/Regulatory Uncertainty: Investors may be hesitant without a clear 510(k) or PMA strategy.
- IP Theft: Sharing too much technical detail on public forums like Reddit or Indie Hackers.
- Niche Saturation: Large incumbents (Medtronic/Abbott) may pivot to dynamic waves quickly if the concept gains too much public traction before IP filing.
Ready to grow your product?
Get a personalised, AI-generated growth plan with audience insights, distribution channels, and a week-by-week execution roadmap.
Create Your Own Growth Plan — Free